WaveMan · Form 4
Chu Yu-Waye insider trades
> Search tickers & screens ⌘K
LIVE

Chu Yu-Waye insider trades

Chu Yu-Waye has filed 15 Form 4s with the SEC that we hold, for Fate Therapeutics INC (FATE) (Chief Medical Officer) and CytomX Therapeutics, Inc. (CTMX) (Chief Medical Officer). Across all of them we count 0 purchases worth $0 and 15 sales worth $918.6K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($136.6K). The largest single trade was a sale of 3,547 shares of Fate Therapeutics INC worth $171.8K, dated 2022-01-11. The first filing on our record is dated 2021-11-22 and the latest 2026-03-19.

Fate Therapeutics INC (FATE)

Chief Medical Officer · 8 filings · 13 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-12-10S, sale reported on Form 41,045$53.4K2021-12-13
2021-12-10S, sale reported on Form 4600$32.7K2021-12-13
2021-12-10S, sale reported on Form 45$2782021-12-13
2021-12-10S, sale reported on Form 41,031$55.3K2021-12-13
2021-12-10S, sale reported on Form 41,822$95.4K2021-12-13
2021-12-10S, sale reported on Form 42,097$103.4K2021-12-13
2021-12-10S, sale reported on Form 4900$45.4K2021-12-13
2022-01-11S, sale reported on Form 43,547$171.8K2022-01-13
2022-01-11S, sale reported on Form 4418$20.5K2022-01-13
2022-04-19S, sale reported on Form 44,062$143.7K2022-04-21
2023-01-10S, sale reported on Form 47,825$41.0K2023-01-11
2023-04-18S, sale reported on Form 4215$1.4K2023-04-19
2023-04-18S, sale reported on Form 42,317$15.2K2023-04-19

CytomX Therapeutics, Inc. (CTMX)

Chief Medical Officer · 7 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-03-18S, sale reported on Form 44,025$2.4K2025-03-20
2026-03-17S, sale reported on Form 421,279$136.6K2026-03-19
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1854586) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms